{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:49:20Z","timestamp":1793051360679,"version":"4.5.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetic peripheral neuropathy (DPN) refers to the development of peripheral nerve dysfunction in patients with diabetes when other causes are excluded. Diabetic distal symmetric polyneuropathy (DSPN) is the most representative form of DPN. As one of the most common complications of diabetes, its prevalence increases with the duration of diabetes. 10-15% of newly diagnosed T2DM patients have DSPN, and the prevalence can exceed 50% in patients with diabetes for more than 10 years. Bilateral limb pain, numbness, and paresthesia are the most common clinical manifestations in patients with DPN, and in severe cases, foot ulcers can occur, even leading to amputation. The etiology and pathogenesis of diabetic neuropathy are not yet completely clarified, but hyperglycemia, disorders of lipid metabolism, and abnormalities in insulin signaling pathways are currently considered to be the initiating factors for a range of pathophysiological changes in DPN. In the presence of abnormal metabolic factors, the normal structure and function of the entire peripheral nervous system are disrupted, including myelinated and unmyelinated nerve axons, perikaryon, neurovascular, and glial cells. In addition, abnormalities in the insulin signaling pathway will inhibit neural axon repair and promote apoptosis of damaged cells. Here, we will discuss recent advances in the study of DPN mechanisms, including oxidative stress pathways, mechanisms of microvascular damage, mechanisms of damage to insulin receptor signaling pathways, and other potential mechanisms associated with neuroinflammation, mitochondrial dysfunction, and cellular oxidative damage. Identifying the contributions from each pathway to neuropathy and the associations between them may help us to further explore more targeted screening and treatment interventions.<\/jats:p>","DOI":"10.3389\/fendo.2023.1265372","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T11:00:17Z","timestamp":1705921217000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":319,"title":["Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment"],"prefix":"10.3389","volume":"14","author":[{"given":"Jinxi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","article-title":"The epidemiology and risk factors of chronic polyneuropathy","volume":"31","author":"Hanewinckel","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.6.1790","article-title":"The health care costs of diabetic peripheral neuropathy in the US","volume":"26","author":"Gordois","year":"2003","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.08.020","article-title":"A new look at painful diabetic neuropathy","volume":"144","author":"Sloan","year":"2018","journal-title":"Diabetes Res Clin Practice"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1836","article-title":"Current challenges and opportunities in the prevention and management of diabetic foot ulcers","volume":"41","author":"Jeffcoate","year":"2018","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/db20182-1","article-title":"Diagnosis and management of diabetic foot complications","volume":"2018","author":"Boulton","year":"2018","journal-title":"Compendia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmy023","article-title":"Proton pump inhibitors, H2-receptor antagonists, metformin, and vitamin B-12 deficiency: clinical implications","volume":"9","author":"Miller","year":"2018","journal-title":"Adv Nutr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14734","article-title":"Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes","volume":"24","author":"Bell","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"m997","DOI":"10.1136\/bmj.m997","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"Br Med J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"l1108","DOI":"10.1136\/bmj.l1108","article-title":"Diagnosis and management of sensory polyneuropathy","volume":"365","author":"Gwathmey","year":"2019","journal-title":"Br Med J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2019.416","article-title":"Williams textbook of endocrinology - 14th revised edition","volume":"15","author":"Badiu","year":"2019","journal-title":"Acta Endocrinologica (Bucharest)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.dsx.2018.03.026","article-title":"Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review","volume":"12","author":"Shabeeb","year":"2018","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/acn3.531","article-title":"Diabetes and obesity are the main metabolic drivers of peripheral neuropathy","volume":"5","author":"Callaghan","year":"2018","journal-title":"Ann Clin Trans Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058783","article-title":"Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters","volume":"8","author":"Kirchmair","year":"2013","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00617","article-title":"Prevalence of and risk factors for peripheral neuropathy in chinese patients with diabetes: A multicenter cross-sectional study","volume":"9","author":"Pan","year":"2018","journal-title":"Front Endocrinology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-444-53480-4.00001-1","article-title":"Epidemiology of polyneuropathy in diabetes and prediabetes","volume":"126","author":"Ziegler","year":"2014","journal-title":"Handb Clin Neurology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01144","article-title":"Prevalence and diagnosis of diabetic cardiovascular autonomic neuropathy in beijing, China: A retrospective multicenter clinical study","volume":"13","author":"Pan","year":"2019","journal-title":"Front Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00496-z","article-title":"Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy","volume":"17","author":"Sloan","year":"2021","journal-title":"Nat Reviews: Endocrinology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2022.0158","article-title":"Emerging nonpharmacologic interventions to treat diabetic peripheral neuropathy","volume":"38","author":"Enders","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0497","article-title":"Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year","volume":"10","author":"Carstens","year":"2021","journal-title":"Stem Cells Trans Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e32653","DOI":"10.1097\/MD.0000000000032653","article-title":"Mechanism of Schwann cells in diabetic peripheral neuropathy: A review","volume":"102","author":"Li","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00188-0","article-title":"Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments","volume":"21","author":"Elafros","year":"2022","journal-title":"Lancet Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/pm\/pnaa164","article-title":"Mechanism of peripheral nerve stimulation in chronic pain","volume":"21","author":"Lin","year":"2020","journal-title":"Pain Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01080-z","article-title":"Peripheral nerve development and the pathogenesis of peripheral neuropathy: the sorting point","volume":"18","author":"Previtali","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1111\/jns.12462","article-title":"Normal structure and pathological features in peripheral neuropathies","author":"Hoke","year":"2021","journal-title":"J Peripheral Nervous System"},{"key":"B26","doi-asserted-by":"publisher","first-page":"105952","DOI":"10.1016\/j.nbd.2022.105952","article-title":"Schwann cell functions in peripheral nerve development and repair","volume":"176","author":"Bosch-Queralt","year":"2023","journal-title":"Neurobiol Disease"},{"key":"B27","doi-asserted-by":"publisher","first-page":"a020529","DOI":"10.1101\/cshperspect.a020529","article-title":"Schwann cell myelination","volume":"7","author":"Salzer","year":"2015","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev-neuro-080317-061853","article-title":"Myelin plasticity and nervous system function","volume":"41","author":"Monje","year":"2018","journal-title":"Annu Rev Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900127R","article-title":"STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy","volume":"33","author":"Du","year":"2019","journal-title":"FASEB J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"117459","DOI":"10.1016\/j.lfs.2020.117459","article-title":"Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy","volume":"248","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"154867","DOI":"10.1016\/j.metabol.2021.154867","article-title":"Management of diabetic neuropathy","volume":"123","author":"Cernea","year":"2021","journal-title":"Metabolism: Clin Experimental"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5345269","DOI":"10.1155\/2022\/5345269","article-title":"Plasticity of the central nervous system involving peripheral nerve transfer","volume":"2022","author":"Shen","year":"2022","journal-title":"Neural Plasticity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/j.pain.0000000000001528","article-title":"Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy","volume":"160","author":"DiAntonio","year":"2019","journal-title":"Int Assoc Study Pain"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24538","article-title":"Peripheral nerve injury and myelination: Potential therapeutic strategies","volume":"98","author":"Modrak","year":"2020","journal-title":"J Neurosci Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.541","article-title":"Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes","volume":"21","author":"Kamiya","year":"2005","journal-title":"Diabetes Metab Res Review"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1372.004","article-title":"Diabetic neuropathy differs in type 1 and type 2 diabetes","volume":"1084","author":"Sima","year":"2006","journal-title":"Ann New York Acad Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3913-8","article-title":"Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns","volume":"59","author":"Hur","year":"2016","journal-title":"Diabetologia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/br.2018.1135","article-title":"Differential gene expression profiling of the sciatic nerve in type 1 and type 2 diabetic mice","volume":"9","author":"Gu","year":"2018","journal-title":"Biomed Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/ijms22010094","article-title":"Pathogenesis and molecular treatment strategies of diabetic neuropathy collateral glucose-utilizing pathways in diabetic polyneuropathy","volume":"22","author":"Mizukami","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.04.010","article-title":"The dynamic plasticity of insulin production in \u03b2-cells","volume":"6","author":"Boland","year":"2017","journal-title":"Mol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","article-title":"Krebs cycle reborn in macrophage immunometabolism","volume":"38","author":"Ryan","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1039\/D1CB00106J","article-title":"Targeted disruption of PKC from AKAP signaling complexes","volume":"2","author":"Limaye","year":"2021","journal-title":"RSC Chem Biol"},{"key":"B44","volume-title":"Stress-induced gastritis","author":"Megha","year":"2023"},{"key":"B45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1871527320666210902165739","article-title":"Neuroprotective role of the B vitamins in the modulation of the central glutamatergic neurotransmission","volume":"21","author":"Huang","year":"2022","journal-title":"CNS Neurological Disord Drug Targets"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-019-09679-w","article-title":"Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen\/glucose deprivation in cortical astrocyte cultures: involvement of A(1) and A(2A) adenosine receptors and PI3K, MEK, and PKC pathways","volume":"15","author":"Dal-Cim","year":"2019","journal-title":"Purinergic Signal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/cells9061553","article-title":"Amyloid proteins and peripheral neuropathy","volume":"9","author":"Asiri","year":"2020","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1306","article-title":"Impaired nociception in the diabetic ins2(+\/akita) mouse","volume":"67","author":"Vastani","year":"2018","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e22594","DOI":"10.1096\/fj.202200757R","article-title":"Insulin stimulates atypical protein kinase C-mediated phosphorylation of the neuronal adaptor FE65 to potentiate neurite outgrowth by activating ARF6-Rac1 signaling","volume":"36","author":"Chau","year":"2022","journal-title":"FASEB J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/pharmaceutics13111748","article-title":"Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials","volume":"13","author":"Kawano","year":"2021","journal-title":"Pharmaceutics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/jns.12392","article-title":"Diabetic polyneuropathy: Bridging the translational gap","volume":"25","author":"Kobayashi","year":"2020","journal-title":"J Peripheral Nervous System"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00349-7","article-title":"Protective effects of novel substituted triazinoindole inhibitors of aldose reductase and epalrestat in neuron-like PC12 cells and BV2 rodent microglial cells exposed to toxic models of oxidative stress: comparison with the pyridoindole antioxidant stobadine","volume":"39","author":"Elmazoglu","year":"2021","journal-title":"Neurotoxicity Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7489795","DOI":"10.1155\/2020\/7489795","article-title":"Association of glycemic indices (Hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications","volume":"2020","author":"Papachristoforou","year":"2020","journal-title":"J Diabetes Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/ijms22031031","article-title":"Aldose reductase and the polyol pathway in schwann cells: old and new problems","volume":"22","author":"Niimi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41598-020-58213-1","article-title":"Nerve damage induced skeletal muscle atrophy is associated with increased accumulation of intramuscular glucose and polyol pathway intermediates","volume":"10","author":"Langer","year":"2020","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0835","article-title":"Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy","volume":"65","author":"Freeman","year":"2016","journal-title":"Diabetes"},{"key":"B57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41387-021-00150-7","article-title":"Elevated myocardial fructose and sorbitol levels are associated with diastolic dysfunction in diabetic patients, and cardiomyocyte lipid inclusions in vitro","volume":"11","author":"Daniels","year":"2021","journal-title":"Nutr Diabetes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12974-023-02740-x","article-title":"Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies","volume":"20","author":"Vargas-Soria","year":"2023","journal-title":"J Neuroinflammation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijms24032927","article-title":"Advanced glycation end-products and diabetic neuropathy of the retina","volume":"24","author":"Oshitari","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13813455.2020.1797106","article-title":"Role of advanced glycation end products and insulin resistance in diabetic nephropathy","volume":"129","author":"Parwani","year":"2023","journal-title":"Arch Physiol Biochem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12950","article-title":"Dual CCR2\/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob\/ob mice","volume":"19","author":"O\u2019Brien","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2146512","DOI":"10.1080\/0886022X.2022.2146512","article-title":"Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention","volume":"45","author":"Ma","year":"2023","journal-title":"Renal Failure."},{"key":"B63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jtos.2017.10.006","article-title":"The impact of diabetes on corneal nerve morphology and ocular surface integrity","volume":"16","author":"Markoulli","year":"2018","journal-title":"Ocular Surface"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/joim.12522","article-title":"C-peptide antioxidant adaptive pathways in \u03b2 cells and diabetes","volume":"281","author":"Luppi","year":"2017","journal-title":"J Internal Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.655591","article-title":"Electroacupuncture alleviates diabetic peripheral neuropathy by regulating glycolipid-related GLO\/AGEs\/RAGE axis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12902-021-00697-7","article-title":"Skin AGEs and diabetic neuropathy","volume":"21","author":"Papachristou","year":"2021","journal-title":"BMC Endocrine Disord"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216736","article-title":"A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE","volume":"14","author":"Zaman","year":"2019","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2174\/157339905774574383","article-title":"The potential role of thiamine (vitamin B1) in diabetic complications","volume":"1","author":"Thornalley","year":"2005","journal-title":"Curr Diabetes Rev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.14.8225","article-title":"Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells","volume":"273","author":"Chen","year":"1998","journal-title":"J Biol Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313524200","article-title":"Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013\/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway","volume":"279","author":"Weigert","year":"2004","journal-title":"J Biol Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000266391.20707.83","article-title":"Microvascular tissue plasminogen activator is reduced in diabetic neuropathy","volume":"69","author":"Hafer-Macko","year":"2007","journal-title":"Neurology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.12.198","article-title":"Reactive oxygen species mediates the apoptosis induced by transforming growth factor beta(2) in human lens epithelial cells","volume":"354","author":"Yao","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/bbrc.1998.8257","article-title":"Cellular responses to DNA damage in the absence of Poly(ADP-ribose) polymerase","volume":"245","author":"Le Rhun","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.14.7303","article-title":"Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells","volume":"94","author":"de Murcia","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF00928438","article-title":"Structure and function of poly(ADP-ribose) polymerase","volume":"138","author":"de Murcia","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2020.1837183","article-title":"Biomarkers in diabetic neuropathy","volume":"129","author":"Adki","year":"2023","journal-title":"Arch Physiol Biochem"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/095530098142428","article-title":"Trans-dominant inhibition of poly(ADP-ribosyl)ation leads to decreased recovery from ionizing radiation-induced cell killing","volume":"73","author":"Rudat","year":"1998","journal-title":"Int J Radiat Biol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/BF00301776","article-title":"Inhibition of the induction of collagenase by interleukin-1 beta in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide","volume":"15","author":"Ehrlich","year":"1995","journal-title":"Rheumatol Int"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2005.7.1568","article-title":"Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme","volume":"7","author":"Pacher","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.10.020","article-title":"Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients","volume":"79","author":"Nikitin","year":"2008","journal-title":"Diabetes Res Clin Practice"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2011.709","article-title":"Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice","volume":"28","author":"Drel","year":"2011","journal-title":"Int J Mol Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2007.09.013","article-title":"PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy","volume":"44","author":"Obrosova","year":"2008","journal-title":"Free Radical Biol Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.05.052","article-title":"The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy","volume":"247","author":"Zhang","year":"2006","journal-title":"J Neurological Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-1342","article-title":"New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}","volume":"151","author":"Drel","year":"2010","journal-title":"Endocrinology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.12.3435","article-title":"Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited","volume":"54","author":"Obrosova","year":"2005","journal-title":"Diabetes"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2005.7.1513","article-title":"Ischemia-reperfusion injury causes oxidative stress and apoptosis of Schwann cell in acute and chronic experimental diabetic neuropathy","volume":"7","author":"Wang","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2014.04.029","article-title":"Recent advances in understanding the role of oxidative stress in diabetic neuropathy","volume":"9","author":"Shakeel","year":"2015","journal-title":"Diabetes Metab Syndrome"},{"key":"B90","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ejphar.2018.06.034","article-title":"Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets","volume":"833","author":"Dewanjee","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.3.711","article-title":"Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy","volume":"53","author":"Obrosova","year":"2004","journal-title":"Diabetes"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0067","article-title":"Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy","volume":"55","author":"Ilnytska","year":"2006","journal-title":"Diabetes"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.11.010","article-title":"Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy","volume":"391","author":"Negi","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.01.037","article-title":"PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function","volume":"50","author":"Lupachyk","year":"2011","journal-title":"Free Radical Biol Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00642.2020","article-title":"Insulin action in the brain regulates both central and peripheral functions","volume":"321","author":"Agrawal","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00581","article-title":"A role for insulin in diabetic neuropathy","volume":"10","author":"Grote","year":"2016","journal-title":"Front Neurosci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/CBI20100523","article-title":"Expression and localization of insulin receptors in dissociated primary cultures of rat Schwann cells","volume":"35","author":"Shetter","year":"2011","journal-title":"Cell Biol Int"},{"key":"B98","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mcn.2004.08.009","article-title":"Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons","volume":"28","author":"Huang","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.13-0184","article-title":"Insulin-ameliorated peripheral motor neuropathy in spontaneously diabetic WBN\/Kob rats","volume":"75","author":"Ozaki","year":"2013","journal-title":"J Veterinary Med Science"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245395","article-title":"Effect of honey and insulin treatment on oxidative stress and nerve conduction in an experimental model of diabetic neuropathy Wistar rats","volume":"16","author":"Sirisha","year":"2021","journal-title":"PloS One"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.03.017","article-title":"Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy","volume":"12","author":"Rachana","year":"2018","journal-title":"Diabetes Metab Syndrome."},{"key":"B102","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.peptides.2012.04.012","article-title":"Developmental regulation of insulin receptor gene in sciatic nerves and role of insulin on glycoprotein P0 in the Schwann cells","volume":"36","author":"Shettar","year":"2012","journal-title":"Peptides"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23755","article-title":"Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy","volume":"68","author":"Hackett","year":"2020","journal-title":"Glia."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.7.1824","article-title":"Direct insulin signaling of neurons reverses diabetic neuropathy","volume":"53","author":"Brussee","year":"2004","journal-title":"Diabetes."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.52.37307","article-title":"Gab1 mediates neurite outgrowth, DNA synthesis, and survival in PC12 cells","volume":"274","author":"Korhonen","year":"1999","journal-title":"J Biol Chem"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)41950-3","article-title":"Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase","volume":"267","author":"Soltoff","year":"1992","journal-title":"J Biol Chem"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5520-03.2004","article-title":"Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination","volume":"24","author":"Ogata","year":"2004","journal-title":"J Neurosci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.08.005","article-title":"Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats","volume":"297","author":"Aghanoori","year":"2017","journal-title":"Exp Neurology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"212571","DOI":"10.1155\/2011\/212571","article-title":"Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy","volume":"2011","author":"Grote","year":"2011","journal-title":"Exp Diabetes Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.04.012","article-title":"Local insulin and the rapid regrowth of diabetic epidermal axons","volume":"43","author":"Guo","year":"2011","journal-title":"Neurobiol Disease"},{"key":"B112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2051-5960-1-15","article-title":"Peripheral nervous system insulin resistance in ob\/ob mice","volume":"1","author":"Grote","year":"2013","journal-title":"Acta Neuropathologica Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron","year":"2001","journal-title":"Diabetologia"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/107.3.935","article-title":"Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy","volume":"107","author":"Tuck","year":"1984","journal-title":"Brain"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3461-z","article-title":"The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy","volume":"58","author":"\u00d8stergaard","year":"2015","journal-title":"Diabetologia."},{"key":"B116","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/ijms22010062","article-title":"Blood-nerve barrier (BNB) pathology in diabetic peripheral neuropathy and in vitro human BNB model","volume":"22","author":"Takeshita","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ana.410370412","article-title":"Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity","volume":"37","author":"Giannini","year":"1995","journal-title":"Ann Neurology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.201","article-title":"Schwann cell interactions with axons and microvessels in diabetic neuropathy","volume":"13","author":"Gon\u00e7alves","year":"2017","journal-title":"Nat Reviews: Neurology"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51563","article-title":"Sciatic nerve microvascular permeability in type 2 diabetes decreased in patients with neuropathy","volume":"9","author":"Jende","year":"2022","journal-title":"Ann Clin Trans Neurology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000723","article-title":"The challenges of diabetic polyneuropathy: a brief update","volume":"32","author":"Zochodne","year":"2019","journal-title":"Curr Opin Neurology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11892-014-0541-x","article-title":"Microvascular dysfunction in the context of diabetic neuropathy","volume":"14","author":"Stirban","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab414","article-title":"Concomitant peripheral neuropathy and type 2 diabetes impairs postexercise cutaneous perfusion and flowmotion","volume":"106","author":"Reyn\u00e8s","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01114","article-title":"Regulatory mechanisms of the wnt\/\u03b2-catenin pathway in diabetic cutaneous ulcers","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/cells12040565","article-title":"Wnt pathway in pancreatic development and pathophysiology","volume":"12","author":"Napolitano","year":"2023","journal-title":"Cells"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06523-7","article-title":"Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders","volume":"34","author":"Marini","year":"2023","journal-title":"Osteoporosis Int"},{"key":"B126","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/bs.ctdb.2023.02.001","article-title":"Visualizing WNT signaling in mammalian systems","volume":"153","author":"van der Wal","year":"2023","journal-title":"Curr Topics Dev Biol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220503","article-title":"WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer","volume":"220","author":"Du","year":"2023","journal-title":"J Exp Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1615","article-title":"Neuroprotective effects of isoquercitrin in diabetic neuropathy via Wnt\/\u03b2-catenin signaling pathway inhibition","volume":"46","author":"Resham","year":"2020","journal-title":"Biofactors"},{"key":"B129","doi-asserted-by":"publisher","first-page":"6897056","DOI":"10.1155\/2022\/6897056","article-title":"Human placenta-derived mesenchymal stem cells ameliorate diabetic neuropathy via wnt signaling pathway","volume":"2022","author":"Pan","year":"2022","journal-title":"Stem Cells Int"},{"key":"B130","doi-asserted-by":"publisher","first-page":"8974960","DOI":"10.1155\/2023\/8974960","article-title":"Liraglutide attenuates hepatic oxidative stress, inflammation, and apoptosis in streptozotocin-induced diabetic mice by modulating the wnt\/\u03b2-catenin signaling pathway","volume":"2023","author":"Yu","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0473-17.2017","article-title":"ERK\/MAPK signaling is required for pathway-specific striatal motor functions","volume":"37","author":"Hutton","year":"2017","journal-title":"J Neurosci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"16730","DOI":"10.1038\/s41598-022-19947-2","article-title":"Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation","volume":"12","author":"Vieira","year":"2022","journal-title":"Sci Rep"},{"key":"B133","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/1566524021666210816093111","article-title":"Diabetic neuropathy: review on molecular mechanisms","volume":"23","author":"Sanaye","year":"2023","journal-title":"Curr Mol Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1051\/rmr\/200001","article-title":"Siwei Jianbu decoction improves painful paclitaxel-induced peripheral neuropathy in mouse model by modulating the NF-\u03baB and MAPK signaling pathways","volume":"8","author":"Suo","year":"2020","journal-title":"Regenerative Med Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.3390\/ijms21186480","article-title":"p38 MAPK in glucose metabolism of skeletal muscle: beneficial or harmful","volume":"21","author":"Bengal","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biomaterials.2018.03.044","article-title":"Heparin-poloxamer thermosensitive hydrogel loaded with bFGF and NGF enhances peripheral nerve regeneration in diabetic rats","volume":"168","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2010.500245","article-title":"Cross-talk between AMPK and mTOR in regulating energy balance","volume":"52","author":"Xu","year":"2012","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.4161\/auto.1.3.2068","article-title":"Sera from patients with type 2 diabetes and neuropathy induce autophagy and colocalization with mitochondria in SY5Y cells","volume":"1","author":"Towns","year":"2005","journal-title":"Autophagy"},{"key":"B139","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.3390\/ijms23084405","article-title":"Docosahexaenoic acid suppresses oxidative stress-induced autophagy and cell death via the AMPK-dependent signaling pathway in immortalized fischer rat schwann cells 1","volume":"23","author":"Tatsumi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B140","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jchemneu.2017.12.011","article-title":"Lycium barbarum polysaccharide protects diabetic peripheral neuropathy by enhancing autophagy via mTOR\/p70S6K inhibition in Streptozotocin-induced diabetic rats","volume":"89","author":"Liu","year":"2018","journal-title":"J Chem Neuroanatomy"},{"key":"B141","doi-asserted-by":"publisher","first-page":"153749","DOI":"10.1016\/j.phymed.2021.153749","article-title":"Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy","volume":"92","author":"Yin","year":"2021","journal-title":"Phytomedicine."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.13157","article-title":"Muscone ameliorates diabetic peripheral neuropathy through activating AKT\/mTOR signalling pathway","volume":"71","author":"Dong","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620761114","article-title":"mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells","volume":"114","author":"Beirowski","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2018.03.034","article-title":"Hyperglycemia-induced Bcl-2\/Bax-mediated apoptosis of Schwann cells via mTORC1\/S6K1 inhibition in diabetic peripheral neuropathy","volume":"367","author":"Zhu","year":"2018","journal-title":"Exp Cell Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-018-2637-1","article-title":"DNMT1, a novel regulator mediating mTORC1\/mTORC2 pathway-induced NGF expression in schwann cells","volume":"43","author":"Cheng","year":"2018","journal-title":"Neurochemical Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.179032","article-title":"Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR","volume":"11","author":"Maiese","year":"2016","journal-title":"Neural Regeneration Res"},{"key":"B147","doi-asserted-by":"publisher","first-page":"111502","DOI":"10.1016\/j.yexcr.2019.111502","article-title":"The Akt\/mTOR cascade mediates high glucose-induced reductions in BDNF via DNMT1 in Schwann cells in diabetic peripheral neuropathy","volume":"383","author":"Zhang","year":"2019","journal-title":"Exp Cell Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201800075","article-title":"The LKB1-AMPK and mTORC1 Metabolic Signaling Networks in Schwann Cells Control Axon Integrity and Myelination: Assembling and upholding nerves by metabolic signaling in Schwann cells","volume":"41","author":"Beirowski","year":"2019","journal-title":"Bioessays"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S337779","article-title":"Prevalence and clinical significance of subclinical hypothyroidism in diabetic peripheral neuropathy","volume":"14","author":"Allam","year":"2021","journal-title":"Int J Gen Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2016.01.018","article-title":"A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients","volume":"115","author":"Zhao","year":"2016","journal-title":"Diabetes Res Clin Practice"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S354872","article-title":"Association of thyroid hormone levels with microvascular complications in euthyroid type 2 diabetes mellitus patients","volume":"15","author":"Hu","year":"2022","journal-title":"Diabetes Metab Syndrome Obes"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_572_17","article-title":"Thyroid status in patients with type 2 diabetes attending a tertiary care hospital in eastern India","volume":"22","author":"Pramanik","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.22092\/ARI.2022.357389.2029","article-title":"Vitamin D level and its relation with the newly diagnosed diabetic neuropathy in women with hypothyroidism","volume":"77","author":"Salman Jasim","year":"2022","journal-title":"Arch Razi Institute"},{"key":"B154","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0168-8227(99)00028-5","article-title":"Beneficial effect of thyrotropin-releasing hormone on neuropathy in diabetic rats","volume":"44","author":"Gul","year":"1999","journal-title":"Diabetes Res Clin Practice"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2482453","DOI":"10.1155\/2021\/2482453","article-title":"TSH combined with TSHR aggravates diabetic peripheral neuropathy by promoting oxidative stress and apoptosis in schwann cells","volume":"2021","author":"Fan","year":"2021","journal-title":"Oxid Med Cell Longevity"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13401","article-title":"Current concepts in the management of diabetic polyneuropathy","volume":"12","author":"Ziegler","year":"2021","journal-title":"J Diabetes Invest"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400603","article-title":"Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)","volume":"38","author":"Ziegler","year":"1995","journal-title":"Diabetologia"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5043-1","article-title":"MR T2 value of the tibial nerve can be used as a potential non-invasive and quantitative biomarker for the diagnosis of diabetic peripheral neuropathy","volume":"28","author":"Wang","year":"2018","journal-title":"Eur Radiology"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27086","article-title":"Metabolic syndrome and peripheral neuropathy","volume":"63","author":"Kazamel","year":"2021","journal-title":"Muscle Nerve."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Br Med J"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314171","article-title":"Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study","volume":"87","author":"Hanewinckel","year":"2016","journal-title":"J Neurology Neurosurg Psychiatry"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association between metabolic syndrome components and polyneuropathy in an obese population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology."},{"key":"B167","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12883-016-0752-7","article-title":"Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study","volume":"16","author":"Vinik","year":"2016","journal-title":"BMC Neurol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.483675","article-title":"Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study","volume":"26","author":"Rehm","year":"2010","journal-title":"Curr Med Res Opinion"},{"key":"B169","doi-asserted-by":"publisher","first-page":"14697","DOI":"10.1038\/s41598-021-94284-4","article-title":"Using corneal confocal microscopy to compare Mecobalamin intramuscular injections vs oral tablets in treating diabetic peripheral neuropathy: a RCT","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci Rep"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12452","article-title":"Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain","volume":"68","author":"Irving","year":"2014","journal-title":"Int J Clin Practice"},{"key":"B171","doi-asserted-by":"publisher","first-page":"111041","DOI":"10.1016\/j.nut.2020.111041","article-title":"An updated systematic review and dose-response meta-analysis of the effects of alpha-lipoic acid supplementation on glycemic markers in adults","volume":"82","author":"Mahmoudi-Nezhad","year":"2021","journal-title":"Nutrition"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2020.0068","article-title":"Efficacy and safety of mecobalamin on peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Sawangjit","year":"2020","journal-title":"J Altern Complementary Med"},{"key":"B173","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.diabres.2013.03.033","article-title":"Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy","volume":"101","author":"Xu","year":"2013","journal-title":"Diabetes Res Clin Practice"},{"key":"B174","doi-asserted-by":"publisher","first-page":"4078695","DOI":"10.1155\/2016\/4078695","article-title":"Clinical trial assessing the efficacy of gabapentin plus B complex (B1\/B12) versus pregabalin for treating painful diabetic neuropathy","volume":"2016","author":"Mimenza Alvarado","year":"2016","journal-title":"J Diabetes Res"},{"key":"B175","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocn.2015.07.028","article-title":"Efficacy and safety of prostaglandin E1 plus lipoic acid combination therapy versus monotherapy for patients with diabetic peripheral neuropathy","volume":"27","author":"Jiang","year":"2016","journal-title":"J Clin Neurosci"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013020","article-title":"Prostaglandin E1 plus methylcobalamin combination therapy versus prostaglandin E1 monotherapy for patients with diabetic peripheral neuropathy: A meta-analysis of randomized controlled trials","volume":"97","author":"Jiang","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B177","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/03007995.2018.1497958","article-title":"Non-pharmacologic treatments for symptoms of diabetic peripheral neuropathy: a systematic review","volume":"35","author":"Amato Nesbit","year":"2019","journal-title":"Curr Med Res Opinion"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.26226\/morressier.617c37317c09fc044a9751b7","article-title":"Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy","volume":"78","author":"Petersen","year":"2021","journal-title":"JAMA Neurol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1265372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T12:30:06Z","timestamp":1718713806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1265372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":178,"alternative-id":["10.3389\/fendo.2023.1265372"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1265372","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"article-number":"1265372"}}